Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer

Oncology Reports ◽

10.3892/or.2013.2434 ◽

2013 ◽

Vol 30 (1) ◽

pp. 499-505 ◽

Author(s):

ZHONG-HUA LI ◽

XIAO-BING ZHANG ◽

XI-QIAN HAN ◽

CONG-RAN FENG ◽

FENG-SHAN WANG ◽

...

Keyword(s):

Breast Cancer ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Antitumor Effects ◽

Deacetylase Inhibitor

Download Full-text

Antitumor Effects of a Novel Phenylbutyrate-Based Histone Deacetylase Inhibitor, (S)-HDAC-42, in Prostate Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-06-0429 ◽

2006 ◽

Vol 12 (17) ◽

pp. 5199-5206 ◽

Author(s):

Samuel K. Kulp ◽

Chang-Shi Chen ◽

Da-Sheng Wang ◽

Ching-Yu Chen ◽

Ching-Shih Chen

Keyword(s):

Prostate Cancer ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Antitumor Effects ◽

Deacetylase Inhibitor

Download Full-text

Histone deacetylase inhibitor suberoyl bis-hydroxamic acid suppresses cell proliferation and induces apoptosis in breast cancer cells

Molecular Medicine Reports ◽

10.3892/mmr.2014.3076 ◽

2014 ◽

Vol 11 (4) ◽

pp. 2908-2912 ◽

Author(s):

XINMIAO YANG ◽

NING ZHANG ◽

ZELIANG SHI ◽

ZHANGYU YANG ◽

XICHUN HU

Keyword(s):

Breast Cancer ◽

Cell Proliferation ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Hydroxamic Acid ◽

Breast Cancer Cells ◽

Deacetylase Inhibitor

Download Full-text

The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells

Oncology Reports ◽

10.3892/or.2011.1488 ◽

2011 ◽

Author(s):

Bridgette Collins-Burow

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Breast Cancer Cells ◽

Trichostatin A ◽

Expression Profiles ◽

Microrna Expression ◽

Deacetylase Inhibitor ◽

Histone Deacetylase Inhibitor Trichostatin

Download Full-text

Phase I-II study of the histone deacetylase inhibitor (HDACi) vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer (MBC): New York Cancer Consortium trial P7703.

10.1158/0008-5472.sabcs-404 ◽

2009 ◽

Author(s):

B Ramaswamy ◽

K Bhalla ◽

B Cohen ◽

C Pellegrino ◽

D Hershman ◽

...

Keyword(s):

Breast Cancer ◽

New York ◽

Metastatic Breast Cancer ◽

Phase I ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Metastatic Breast ◽

Deacetylase Inhibitor

Download Full-text

A Phase II Study of the Histone Deacetylase Inhibitor, Vorinostat, in Combination with Trastuzumab in Patients with Advanced Metastatic and/or Local Chest Wall Recurrent HER-2 Amplified Breast Cancer Resistant to Transtuzumab-Containing Therapy: (E1104) a Trial of the Eastern Cooperative Oncology Group.

10.1158/0008-5472.sabcs-09-5084 ◽

2009 ◽

Author(s):

R. Swaby ◽

M. Wang ◽

J. Sparano ◽

K. Bhalla ◽

N. Meropol ◽

...

Keyword(s):

Breast Cancer ◽

Histone Deacetylase ◽

Phase Ii ◽

Histone Deacetylase Inhibitor ◽

Phase Ii Study ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Deacetylase Inhibitor ◽

Download Full-text

Abstract P1-07-01: Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin

10.1158/0008-5472.sabcs13-p1-07-01 ◽

2013 ◽

Author(s):

GJ Sabnis ◽

P Shah ◽

A Kazi ◽

Y Gau ◽

S Chumsri ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Breast Cancer Cells ◽

Epithelial To Mesenchymal Transition ◽

Mesenchymal Transition ◽

Deacetylase Inhibitor ◽

Download Full-text

Abstract P6-12-14: Histone deacetylase inhibitor suberoylanilide hydroxamic acid targets breast cancer stem cells and inhibits metastasis

10.1158/0008-5472.sabcs13-p6-12-14 ◽

2013 ◽

Author(s):

K Chu ◽

TL Green ◽

KM Boley ◽

M Cristofanilli ◽

FM Robertson

Keyword(s):

Breast Cancer ◽

Cancer Stem Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Hydroxamic Acid ◽

Suberoylanilide Hydroxamic Acid ◽

Breast Cancer Stem Cells ◽

Deacetylase Inhibitor

Download Full-text

Abstract 4718: Potent preclinical antitumor effects induced by pan-histone deacetylase inhibitor panobinostat in combination with sorafenib in hepatocellular carcinoma

10.1158/1538-7445.am2012-4718 ◽

2012 ◽

Author(s):

Sara Toffanin ◽

Anja Lachenmayer ◽

Clara Alsinet ◽

Laia Cabellos ◽

Beatriz Minguez ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Antitumor Effects ◽

Deacetylase Inhibitor

Download Full-text

Abstract 5847: A histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth with apoptosis in triple-negative breast cancer cells

10.1158/1538-7445.am2018-5847 ◽

2018 ◽

Author(s):

Hisako Ono ◽

Yoshihiro Sowa ◽

Yosuke Iizumi ◽

Mano Horinaka ◽

Tetsuya Taguchi ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Triple Negative Breast Cancer ◽

Histone Deacetylase Inhibitor ◽

Breast Cancer Cells ◽

Triple Negative ◽

Deacetylase Inhibitor

Download Full-text

Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells

Molecular Cancer ◽

10.1186/1476-4598-9-274 ◽

2010 ◽

Vol 9 (1) ◽

pp. 274 ◽

Author(s):

Yuanyuan Li ◽

Yih-Ying Yuan ◽

Syed M. Meeran ◽

Trygve O. Tollefsbol

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Histone Deacetylase ◽

Green Tea ◽

Histone Deacetylase Inhibitor ◽

Breast Cancer Cells ◽

Estrogen Receptor Alpha ◽

Tea Polyphenol ◽

Deacetylase Inhibitor ◽

Green Tea Polyphenol

Download Full-text